Idiopathic CD4 Lymphocytopenia

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

September 10, 2013

Primary Completion Date

September 6, 2017

Study Completion Date

September 6, 2017

Conditions
Idiopathic CD4 Lymphocytopenia
Interventions
BIOLOGICAL

Constitution of a biobank of frozen cells, plasma and serum samples

Depending on clinical presentation and based on previous data obtained by our group, we will investigate the immune responses against Human papilloma virus (HPV), Cryptococcus neoformans,implication of chemokines involved in lymphocyte migration (CXCR4 and CCR7 receptors) and signalisation in response to cytokines controlling LT CD4+ homeostasis (IL-7 et IL-2).

GENETIC

Genetic study

High rate genome wide genetic screening, investigation of mutations associated with identified primary immune deficiencies (adenosine deaminase et class II MHC)

Trial Locations (1)

75014

Cochin Hospital, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02113930 - Idiopathic CD4 Lymphocytopenia | Biotech Hunter | Biotech Hunter